Redox Science Meets Medicine at the 26th International Conference on Redox Medicine 2024 this June in Paris
Redox Science Meets Medicine at the 26th International Conference on Redox Medicine 2024 this June in Paris
The 26th International Conference on Redox Medicine 2024 will take place this month, on June 27-28 at Fondation Biermans-Lapôtre in Paris, France.
With 41+ communications and participants from 20 different countries, the conference promises a diverse exchange of knowledge and ideas.
The sessions of the conference are organized around key topics, with each speaker addressing a specific aspect of redox research:
Keynote Presentations:
Miria Ricchetti, Institut Pasteur, France Redox Medicine: A Biologist Point of View
Bruce Freeman, University of Pittsburgh, USA Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development
Redox Signaling and Disease Mechanisms:
Mario D. Cordero, Universidad Pablo de Olavide, Spain Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling
Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, France Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
Metabolic Regulation and Health:
Martin O. Bergo, Karolinska Institutet, Sweden Antioxidants Stimulate Blood Flow in Tumors
Tamara Tomin, Technical University of Wien, Austria Metabolic Regulation by Redox Signaling in the Heart
Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner
Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus
Redox Biology and Aging:
Roberta Rizzo, Università degli Studi di Ferrara, Italy NADH: The Redox Sensor in Aging-Related Disorders
Clinical Applications and Implications:
Andrew Cumpstey, University of Southampton, United Kingdom Redox Implications of Supplementary Oxygen during Major Abdominal Surgery
Daniel Vaiman, DR1 INSERM, Institut Cochin, France New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy
Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France Redox, Radiotherapy, and Biomarkers
Biomarkers in Health & Disease:
Carole Nicco, President of Redox Medicine Society Redox Medicine 2024: Biomarkers
Sayuri Miyamoto, University of São Paulo, Brazil Identifying Oxidized Lipids in Neurodegenerative Diseases
Jumana Saleh, Sultan Qaboos University, Oman Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity
Neurodegenerative Diseases and Drug Development:
Jeffrey A. Johnson, University of Wisconsin, USA Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases
George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus Drug repurposing on Alzheimer's Disease & NRF2 Modulation
Pharmaceutical Approaches and Artificial Intelligence:
Duncan Emerton, Vice-President of Citeline, United Kingdom Pharma’s Search for Redox-Modulating Therapeutics
Antonio Vila-Coro, IQVIA, Spain How to Develop a Drug – From Preclinical to Clinical
Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris Artificial Intelligence in NeuroInflammation, Biomarkers, and Redox Medicine
Maxime Barat, Université Paris Cité, Hôpital Cochin, France Artificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology
The Redox Medicine Society is Still Accepting Abstracts
Abstract submissions for poster or short oral presentations are still being accepted. Redox Medicine 2024 conference aims to foster collaboration, facilitate networking, and inspire new research directions in redox medicine.
Supporters 2024: Citeline and Mitologics
For more information about Redox Medicine 2024, please visit: https://www.redox-medicine.com/.
END
The 26th International Conference on Redox Medicine 2024 will take place this month, on June 27-28 at Fondation Biermans-Lapôtre in Paris, France.
With 41+ communications and participants from 20 different countries, the conference promises a diverse exchange of knowledge and ideas.
The sessions of the conference are organized around key topics, with each speaker addressing a specific aspect of redox research:
Keynote Presentations:
Miria Ricchetti, Institut Pasteur, France Redox Medicine: A Biologist Point of View
Bruce Freeman, University of Pittsburgh, USA Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development
Redox Signaling and Disease Mechanisms:
Mario D. Cordero, Universidad Pablo de Olavide, Spain Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling
Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, France Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
Metabolic Regulation and Health:
Martin O. Bergo, Karolinska Institutet, Sweden Antioxidants Stimulate Blood Flow in Tumors
Tamara Tomin, Technical University of Wien, Austria Metabolic Regulation by Redox Signaling in the Heart
Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner
Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus
Redox Biology and Aging:
Roberta Rizzo, Università degli Studi di Ferrara, Italy NADH: The Redox Sensor in Aging-Related Disorders
Clinical Applications and Implications:
Andrew Cumpstey, University of Southampton, United Kingdom Redox Implications of Supplementary Oxygen during Major Abdominal Surgery
Daniel Vaiman, DR1 INSERM, Institut Cochin, France New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy
Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France Redox, Radiotherapy, and Biomarkers
Biomarkers in Health & Disease:
Carole Nicco, President of Redox Medicine Society Redox Medicine 2024: Biomarkers
Sayuri Miyamoto, University of São Paulo, Brazil Identifying Oxidized Lipids in Neurodegenerative Diseases
Jumana Saleh, Sultan Qaboos University, Oman Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity
Neurodegenerative Diseases and Drug Development:
Jeffrey A. Johnson, University of Wisconsin, USA Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases
George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus Drug repurposing on Alzheimer's Disease & NRF2 Modulation
Pharmaceutical Approaches and Artificial Intelligence:
Duncan Emerton, Vice-President of Citeline, United Kingdom Pharma’s Search for Redox-Modulating Therapeutics
Antonio Vila-Coro, IQVIA, Spain How to Develop a Drug – From Preclinical to Clinical
Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris Artificial Intelligence in NeuroInflammation, Biomarkers, and Redox Medicine
Maxime Barat, Université Paris Cité, Hôpital Cochin, France Artificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology
The Redox Medicine Society is Still Accepting Abstracts
Abstract submissions for poster or short oral presentations are still being accepted. Redox Medicine 2024 conference aims to foster collaboration, facilitate networking, and inspire new research directions in redox medicine.
Supporters 2024: Citeline and Mitologics
For more information about Redox Medicine 2024, please visit: https://www.redox-medicine.com/.
END
Attachments
